Skip to content

Research resources and infrastructure

Share
Share
  • Research at the BDI is enabled and underpinned by access to unparalleled, world-leading research infrastructure

Monash University is committed to providing world-class research infrastructure to support our strong research community. 

We have made a series of recent major investments into research infrastructure. Monash now has a world-class integrated network of technology platforms in the areas of biomedicine, science and engineering. These platforms underpin our research efforts as well as provide access to our industry and collaborative research partners. 

These are made up of core facilities and capabilities that provide high-quality specialist research services.

Our equipment is state-of-the-art. Our operators are internationally regarded as the best in the field, and our network of core technology research platforms provides a one-stop technology shop. Our strong governance, oversight and maintenance contracts ensures a seamless user experience.

We have lifted many of these core technologies out of schools and departments to make them more broadly available to our collaborating industry partners and the wider research community.

We aim to build a community of researchers who want to engage in the highest quality, innovative research.

Our core technology research platforms are coordinated through the Office of the Vice-Provost (Research and Research Infrastructure). This ensures our platforms offer a seamless user experience, with strong governance, oversight and maintenance contracts in place.

For more information, visit the Monash Technology Research Platforms site. Our platforms include:

  • Monash Antibody Technologies Facility (MATF)
    MATF uses high-speed robotic platforms to produce custom-made, high-quality, high-affinity monoclonal antibodies for scientific and medical research.
  • Monash Biomedical Imaging (MBI)
    MBI is a Monash University-led group of biomedical imaging facilities across our partner organisations that include hospitals and research organisations. We facilitate imaging research in preclinical and clinical X-Ray, CT, PET, SPECT and MRI. 
  • Monash Biomedical Proteomics Facility (Certified ISO9001)
    Biomedical Proteomics provides a suite of fully automated mass spectrometry (MS) equipment and expertise to provide researchers with the information needed to understand the role of proteins and to help identify potential markers of disease, and targets for therapy.
  • Centre for Drug Candidate Optimisation (CDCO)
    The CDCO is a collaborative research centre that provides drug candidate optimisation services and supports emerging drug discovery and development programs.
  • Monash Centre for Electron Microscopy (MCEM)
    MCEM is a purpose-built facility that offers first-class research and expertise in electron microscopy and atom probe microscopy.
  • FishCore
    FishCore is home to the largest zebrafish facility in the southern hemisphere. Zebrafish are important research models in regenerative medicine.
  • FlowCore
    FlowCore is a core flow cytometry unit that provides services to researchers within Monash and the wider scientific community. Our high-speed laser technology helps researchers generate data about the size, shape, and proteins associated with cells or particles of interest.
  • Monash Macromolecular Crystallisation Facility
    This facility provides high-throughput protein crystallisation of proteins that can provide a basis for understanding protein function and the rational design of therapeutics.
  • Micromon (Certified ISO9001)
    This facility provides fast turnaround in a range of DNA technologies. Our core facilities include long-read DNA Sequencing and Next-Generation Sequencing.
  • Medical Genomics Facility – Monash Health Translation Precinct (MHTP) (NATA Accredited)
    This facility is located at the MHTP and provides a range of enabling genomic technologies.
  • Monash Protein Production Unit (PPU)
    PPU offers expertise in protein expression, purification and optimisation using the latest high-throughput platforms.
  • Monash Histology (Certified ISO9001)
    We provide expert service, advice and training for histological studies involving tissues embedded in paraffin and glycolmethacrylate. We also offer cryostat facilities for frozen specimens.
  • Monash Bioinformatics Platform
    This platform offers bioinformatics support to Monash, international biological researchers and industrial users.
  • Monash Statistical Consulting Platform
    The Monash Statistical Consulting Platform provides assistance to students, researchers and industry with statistical data analysis, forecasting models, design surveys and in-house training.
  • The Clive and Vera Ramaciotti Centre for Structural Cryo Electron Microscopy (Manager: Georg Ramm)
    The centre houses a unique $5m electron microscope (EM), which aims to transform the way we view the human immune system, and advance Australian research into diseases as diverse as cancer, malaria, diabetes, rheumatism and multiple sclerosis.
  • Monash Animal Research Platform (MARP)
    MARP provides laboratory animal services from several facilities across the Clayton and Parkville campuses of Monash University and at
its Gippsland Field Station.
  • Monash Immersive Visualisation Platform (MIVP)
    MIVP operates Monash University's advanced, immersive and large scale visualisation facilities, ranging from the ultrascale CAVE2TM down to personal head-mounted virtual reality (VR) devices like Oculus Rift.
  • Monash Micro Imaging (MMI) 
    MMI is a world class imaging facility, consisting of several core laboratories at Clayton Campus, Monash Health Translation Precinct (MHTP, Clayton) and Alfred Medical Research and Education Precinct (AMREP, Prahran). MMI provides instrumentation, expertise and training in advanced light microscopy and all fluorescence modalities. 
  • Monash Gene Targeting Facility
    The Monash Gene Targeting facility consists of Gene Recombineering, ES Cell and Gene Targeting and has an established track record of delivering targeting and transgenic constructs for any animal models, targeted mouse/rat ES clones and knock in/out transgenic mice or rats.